Initiatives to Promote Quality Management

The Fujifilm Group’s belief that assuring uniformity in the quality and providing a stable supply of products we have developed is the basis to earn customers’ trust and contribute to society. We have retained this belief as the foundation of our business activities since the company’s founding.
We offer products and services across a wide range of business fields, represented by digital cameras, medical imaging systems, BIO CDMO, LS solutions, and document systems such as printers and multifunction devices, as well as semiconductor materials and display materials. Amid the drastic changes in the market and the great technological advances brought about by recent digitization, we intend to continue meeting the expectations and trust of our customers in all our business fields through development and management, as well as to continue to update our comprehensive quality management systems for our products and services.

To enable us to deliver products and services of the highest quality, the Fujifilm Group has established a Quality Policy and based on its principles, has been pursuing improvements in quality and reductions in risk. We have also implemented an integrated management system (IMS)^*1, which includes the quality management system that is chiefly for our manufacturing division in compliance with ISO 9001, to increase the effect of improvements.

• *1 IMS: Integrated management system. The IMS integrates multiple management systems, including an environmental management system (EMS), quality management system (QMS) and occupational safety and health management system (OSHMS).

The Fujifilm Group operates its businesses based on this policy in order to provide the highest quality of products and services to customers.

1. We will seek to ensure customer’s satisfaction and trust in response to the demands of society.
2. We will pursue the highest standard quality in the market by taking advantage of our leading-edge, proprietary technologies. We will also strive for the highest quality and safety.
3. We will thoroughly comply with laws and regulations regarding our products and services.
4. We will correctly and properly disclose information regarding the quality and safety of our products and services.
5. We will listen carefully to market opinions and commit to further sustainable quality improvement continuously.

In the development of new products (including improvements to existing products), the Fujifilm Group conducts verifications at each stage of the development process from product planning to product review, examining not only the level of achievement and quality targets but also environmental matters, safety and statutory regulations, as well as reviews from the viewpoint of user.

The Fujifilm Group upholds its attention to products and services in a safe and responsible manner in its Charter for Corporate Behavior and works to improve product safety levels in compliance with the legal requirements of each country. At the same time, product safety management is implemented uniformly throughout the Group based on the Product Safety Management Regulations. Management organizations responsible for product safety report directly to the president in each operating company. Should an incident occur, systems are in place for close communication and swift action.

In response to the amendments to the Japan’s Consumer Product Safety Act in May 2007, a database for reports on information related to product liability (PL^*2) has been created to speed up information gathering and communication.
Should there be a major product liability incident, the Total Risk Management Committee conducts a review, with the Secretariat coordinating with the relevant business division to implement swift action. For other incidents, the regular ESG Committee conducts a review to ensure group-wide implementation of all continual improvements. If it is necessary to issue guidance to customers, a warning is issued through the “Important Notice to Customers” on our website. We will continue to implement comprehensive product safety management and disclose information whenever appropriate.

There have been no serious incidents that fall under the Consumer Product Safety Act revised in May 2007.

• *2 PL: Product liability

Fujifilm has not conducted nor outsourced testing on animals for the product development of cosmetics (including non-medical products), nor do we have plans to do so in the future.*³

In addition, our policy is to not procure raw materials that have undergone animal experiments after April 1, 2017.
 

• *3 Except in the event that we have an accountability for safety to society or when required by the government in some countries.

Amid the digitization wave of recent years, the new technological innovations and cutting-edge advances that are required are not easily achieved with speed and impact solely through independent development by the company itself; they also require collaboration with a broad range of business partners outside the company.To trigger reform in society and achieve major innovations that can contribute to resolving social issues, we are committed to and are actively promoting “Open Innovation” implemented through co-creation and collaborations founded on equal partnerships among equal business partners.

We are involved in activities to create new value, chiefly in the segment of healthcare and highly functional materials, and innovative products and services and new business operations through active collaboration among the industrial, governmental and academic sectors.

We created an Open Innovation Hub in 2014 in Roppongi, Tokyo to provide a venue for Open Innovation founded on equal, co-creation partnerships with outside organizations. This was followed by formation of a bilateral organization involving a site in Germany with more than 5,300 companies and approx. 27,000 customers in total (as of March 31, 2024). At 15% of these customers, we are promoting discussions and activities to create concrete plans for new products and technologies.
Teleconferencing and virtual tour systems that enable interactive communication has been introduced to enable the skillful management of online and off-line activities in line with the state of the pandemic, enabling us to continue Open Innovation with our customers since 2020.

Of the numerous collaborative R&D projects with outside organizations, we have focused especially in recent years on activities targeting needs in the medical field and solutions to optimize workflows, including assistance with diagnostic medical imaging systems, support with medical site workflows and maintenance services for medical equipment. In addition to our own technological development efforts, we have established partnerships with domestic and overseas AI technology vendors who have outstanding technologies to develop solutions for medical diagnosis assistance through imaging and to achieve greater workflow efficiency. AI technology that can be utilized in these areas is deployed under the brand name REiLI. Many technology development projects are underway in cooperation with universities and research institutes.

In development themes related to the environment, we are actively participating in various industry-academiagovernment collaboration projects that come under the New Energy and Industrial Technology Development Organization (NEDO). Through these activities, we have been recognized as a “Zero-Emissions Challenge” company^*4 by the Ministry of Economy, Trade and Industry (METI).

• *4 Companies taking on the Zero-Emissions^*5 Challenge: project of the Ministry of Economy, Trade and Industry to create a list of companies that are tackling innovation in building a decarbonized society to provide beneficial information to investors and other interested parties. In TCFD Summit 2021 held on October 5, 2021, roughly 600 companies were announced as taking on the Zero-Emissions Challenge.
• *5 Achieving zero CO₂ emissions in this case.